An in vitro study on lung cancer revealed that adiponectin can suppress the proliferation of lung cancer cells by inhibiting the PI3K/Akt signaling pathway and the phosphorylation of mTOR (mammalian target of rapamycin) (140). Here, ADIPOQ is linked to lung carcinoma.